Pregabalin Withdrawn Phase 2 Trials for Diabetes Mellitus (DM) / Pain, Neuropathic Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02673866Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)